Answers are grounded in this paper and cite their sources.
Background Intestinal barrier dysfunction is an important component of sepsis-associated organ dysfunction, yet objective clinical assessment remains difficult. Circulating biomarkers may capture aspects of epithelial injury, permeability-associated processes and functional enterocyte reserve. We combined bibliometric evidence mapping with a prespecified biomarker-specific systematic review and meta-analysis of intestinal fatty acid-binding protein (I-FABP), D-lactate and citrulline. Methods The evidence map included English-language articles and reviews indexed in the Web of Science Core Collection and Scopus from 2006 through 2025. The systematic review searched PubMed/MEDLINE, Embase, Web of Science Core Collection, Scopus and the Cochrane Library from inception to May 1, 2026. Biomarker-specific outcomes were summarized as Hedges’ g under random-effects models, with between-study variance estimated by restricted maximum likelihood. Hartung-Knapp-Sidik-Jonkman confidence intervals were used when at least three studies contributed to an analysis. Results The evidence map included 783 publications and showed growth in mechanistic research on intestinal permeability, tight-junction disruption, microbial or endotoxin translocation, gut microbiota, inflammation and gastrointestinal dysfunction. Nine studies involving 577 patients contributed to the systematic review. For short-term mortality, I-FABP showed no clear difference between non-survivors and survivors ( g = 0.50, 95% CI −0.99 to 1.99; P = 0.285; I 2 = 75.3%; tau 2 = 0.268), whereas D-lactate was higher in non-survivors ( g = 0.63, 95% CI 0.14 to 1.12; P = 0.026; I 2 = 35.9%; tau 2 = 0.041). Citrulline showed no clear mortality-related difference ( g = 0.12, 95% CI −0.40 to 0.63; P = 0.657; I 2 = 0%; tau 2 = 0). Non-mortality citrulline findings were not pooled because gastrointestinal failure/acute gastrointestinal injury and acute respiratory distress syndrome represented clinically distinct outcomes; both were reported as separate single-study findings. Conclusions I-FABP, D-lactate and citrulline reflect different biological dimensions of sepsis-associated intestinal barrier dysfunction and should not be treated as interchangeable measures. Among the three biomarkers, D-lactate showed the most consistent mortality-related elevation, I-FABP results varied substantially between studies, and the association between citrulline and short-term mortality remained unclear. The field is mechanistically rich, but standardized human evidence remains limited; future studies should align biomarkers with prespecified clinical outcomes and evaluate their incremental information beyond routine clinical assessment.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: